openPR Logo
Press release

Pneumococcal Vaccines Market Insights 2019? by Top Key Players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc

07-16-2019 12:24 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Business Industry

Pneumococcal Vaccines

Pneumococcal Vaccines

High mortality due to pneumonia among the global population is expected to increase adoption of pneumococcal vaccines over the forecast period. For instance, according to the World Health Organization (WHO) November 2016, pneumonia accounted for 16% of all deaths of children under 5 years old in 2015, with 920,136 deaths globally.

Furthermore, increasing partnership among Global Alliance for Vaccines and Immunization (GAVI) and key vendors to deliver pneumococcal vaccines in emerging countries is expected to be a significant growth factor for the market.

Free Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/2295

For instance, in March 2016, GSK (Glaxo Smith Kline) announced the introduction of pneumococcal vaccine at the lowest price - US$ 3.05 from 2017, a reduction of 10% from the 2016 price (US$ 3.40). Such tiered pricing approach enables emerging economies to meet demand for vaccines for large proportions of the target population. This price is set to be available through the pilot Advance Market Commitment (AMC) to all GAVI countries. Moreover, the vaccine will be sold at the same price for 10 years after transition.

North America is expected to be the dominant region for pneumococcal vaccines market. This is majorly due to presence of key players in the region, which are focused on gaining regulatory approvals for novel pneumococcal vaccines.

Moreover, increasing mortality rate associated with pneumonia, growing awareness regarding pneumonia infection, and its underlying symptoms among the U.S. population are expected to contribute to significant market growth in the region during the forecast period. For instance, according to the American Lung Association: 2015, around 56,832 deaths were registered due to pneumonia and influenza in 2013, which combined were the eighth leading cause of death in the U.S.

Growing healthcare infrastructure in emerging economies such as India and China and increasing initiatives by government bodies to include pneumococcal vaccine in their respective healthcare immunization programs contribute to wider adoption of pneumococcal vaccines in Asia Pacific. For instance, in November 2016, China Food and Drug Administration (CFDA) approved Pfizer, Inc.’s pneumococcal vaccine Prevenar 13, which is indicated to help prevent pneumococcal disease in infants aged between 6 weeks to 15 months.

Moreover, in 2017, Government of India, in collaboration with GAVI, launched Pneumococcal Conjugate Vaccine (PCV) vaccines in three states of the country at low cost. Furthermore, under this partnership, 60% of all GAVI-procured vaccines will be manufactured in India.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2295

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumococcal Vaccines Market Insights 2019? by Top Key Players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc here

News-ID: 1805033 • Views:

More Releases from Coherent Market Insights - Business Industry

Veterinary Vaccines Market Revenue 2019 | Develop Rapidly by Zoetis Inc. Merck Animal Health, Merial Inc., Boehringer Ingelheim, Bayer Animal Health
Veterinary Vaccines Market Revenue 2019 | Develop Rapidly by Zoetis Inc. Merck A …
Global Veterinary Vaccines Market Research Reports offers valuable insights and market trends to present the Veterinary Vaccines Market performance. The introduction, product details, Veterinary Vaccines marketing strategies, market share and key drivers are stated. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Veterinary Vaccines Industry competitive structure is elaborated. The industry trends, Veterinary Vaccines Market trends,
Biosimilar Pipeline Analysis Market Revenue 2019 | Develop Rapidly by Pfizer Inc., Novartis AG, Biocon, F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca
Biosimilar Pipeline Analysis Market Revenue 2019 | Develop Rapidly by Pfizer Inc …
Global Biosimilar Pipeline Analysis Market Research Reports offers valuable insights and market trends to present the Biosimilar Pipeline Analysis Market performance. The introduction, product details, Biosimilar Pipeline Analysis marketing strategies, market share and key drivers are stated. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Biosimilar Pipeline Analysis Industry competitive structure is elaborated. The industry trends,
Pharmacovigilance Market Revenue 2019 | Develop Rapidly by Accenture, Cognizant, PAREXEL International Corporation, IBM Corporation, Clinquest Group B.V., Wipro Ltd, Oracle Corporation, Foresight Group International AG
Pharmacovigilance Market Revenue 2019 | Develop Rapidly by Accenture, Cognizant, …
Global Pharmacovigilance Market Research Reports offers valuable insights and market trends to present the Pharmacovigilance Market performance. The introduction, product details, Pharmacovigilance marketing strategies, market share and key drivers are stated. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Pharmacovigilance Industry competitive structure is elaborated. The industry trends, Pharmacovigilance Market trends, key drivers, major market segments
Biologics Market Revenue 2019 | Develop Rapidly by AbbVie, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck and Co., Merck KGaA, Novartis, Pfizer
Biologics Market Revenue 2019 | Develop Rapidly by AbbVie, Amgen, AstraZeneca, B …
Global Biologics Market Research Reports offers valuable insights and market trends to present the Biologics Market performance. The introduction, product details, Biologics marketing strategies, market share and key drivers are stated. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Biologics Industry competitive structure is elaborated. The industry trends, Biologics Market trends, key drivers, major market segments

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion